Home>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Sulfamonomethoxine

Sulfamonomethoxine Sale

(Synonyms: 磺胺间甲氧嘧啶) 目录号 : GC32211

Sulfamonomethoxine is a long-acting sulfonamide antibacterial agent and blocks the synthesis of folic acid by inhibiting synthetase of dihydropteroate.

Sulfamonomethoxine Chemical Structure

Cas No.:1220-83-3

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥589.00
现货
10mg
¥536.00
现货
50mg
¥714.00
现货
100mg
¥893.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

产品描述

Sulfamonomethoxine is a long-acting sulfonamide antibacterial agent and blocks the synthesis of folic acid by inhibiting synthetase of dihydropteroate.

Chemical Properties

Cas No. 1220-83-3 SDF
别名 磺胺间甲氧嘧啶
Canonical SMILES O=S(C1=CC=C(N)C=C1)(NC2=NC=NC(OC)=C2)=O
分子式 C11H12N4O3S 分子量 280.3
溶解度 DMSO : ≥ 42 mg/mL (149.84 mM) 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 3.5676 mL 17.838 mL 35.6761 mL
5 mM 0.7135 mL 3.5676 mL 7.1352 mL
10 mM 0.3568 mL 1.7838 mL 3.5676 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

Research Update

Degradation of Sulfamonomethoxine in solution using pulsed plasma discharge - identification of by-products and toxicity of treated solution to green algae

Water Sci Technol 2022 Nov;86(9):2430-2440.PMID:36378190DOI:10.2166/wst.2022.341.

This study investigated the degradation of Sulfamonomethoxine (SMM) by pulsed plasma discharge. SMM was successfully degraded following the first-order kinetics model. The percentage removal of SMM was estimated by the total input energy of plasma discharge, which was dependent on the initial SMM concentration. In addition, three types of by-products were observed at an early reaction time, which were then degraded. In contrast, the ecotoxicity of the treated solution by plasma discharge was assessed by an acute toxicity test using the green alga Raphidocelis subcapitata. The plasma discharge in water generated hydrogen peroxide with a concentration higher than the EC50 for R. subcapitata. It is therefore necessary to remove H2O2 or prevent the generation of H2O2 for the degradation of antibiotics in solutions using plasma discharge.

Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia

Hepatology 2021 Sep;74(3):1461-1479.PMID:33813748DOI:10.1002/hep.31846.

Background and aims: Hypoxia is a common feature of the tumor microenvironment (TME), which promotes tumor progression, metastasis, and therapeutic drug resistance through a myriad of cell activities in tumor and stroma cells. While targeting hypoxic TME is emerging as a promising strategy for treating solid tumors, preclinical development of this approach is lacking in the study of HCC. Approach and results: From a genome-wide CRISPR/CRISPR-associated 9 gene knockout screening, we identified aldolase A (ALDOA), a key enzyme in glycolysis and gluconeogenesis, as an essential driver for HCC cell growth under hypoxia. Knockdown of ALDOA in HCC cells leads to lactate depletion and consequently inhibits tumor growth. Supplementation with lactate partly rescues the inhibitory effects mediated by ALDOA knockdown. Upon hypoxia, ALDOA is induced by hypoxia-inducible factor-1伪 and fat mass and obesity-associated protein-mediated N6 -methyladenosine modification through transcriptional and posttranscriptional regulation, respectively. Analysis of The Cancer Genome Atlas shows that elevated levels of ALDOA are significantly correlated with poor prognosis of patients with HCC. In a screen of Food and Drug Administration-approved drugs based on structured hierarchical virtual platforms, we identified the Sulfamonomethoxine derivative compound 5 (cpd-5) as a potential inhibitor to target ALDOA, evidenced by the antitumor activity of cpd-5 in preclinical patient-derived xenograft models of HCC. Conclusions: Our work identifies ALDOA as an essential driver for HCC cell growth under hypoxia, and we demonstrate that inhibition of ALDOA in the hypoxic TME is a promising therapeutic strategy for treating HCC.

Transformation kinetics and pathways of Sulfamonomethoxine by UV/H2O2 in swine wastewater

Chemosphere 2021 Feb;265:129125.PMID:33276994DOI:10.1016/j.chemosphere.2020.129125.

Sulfamonomethoxine (SMM), as one of the most predominant antibiotics in animal wastewater, is pending for effective control to minimize its environmental risks. Transformation kinetics and pathways of SMM by UV/H2O2 in swine wastewater were systematically investigated in this study. Direct UV photolysis (as a dominant role) and 鈭橭H oxidation contributed to SMM degradation in UV/H2O2 system. The less effective reaction rate of SMM in real wastewater than synthetic wastewater (0.1-0.17 vs. 鈭?.2-1.5 min-1, despite higher H2O2 dosage and extended reaction time) resulted mainly from the abundant presence of conventional contaminants (indicated by COD, a notable competitor of SMM) in real wastewater. SMM degradation benefited from higher H2O2 dosage and neutral and weak alkaline conditions. However, the effect of initial SMM concentration on SMM degradation in synthetic and real wastewater showed opposite trends, owning to the different probability of SMM molecules to interact with UV and H2O2 in different matrices. Carbonate had an inhibitory effect on SMM degradation by scavenging 鈭橭H and pH-variation induced effect, while nitrate promoted SMM degradation by generating more 鈭橭H. The removal efficiency of SMM in real wastewater reached 91% under the reaction conditions of H2O2 of 10 mM, reaction time of 60 min, and pH 6.7-6.9. SMM degradation pathway was proposed as hydroxylation of benzene and pyrimidine rings, and secondary amine, and the subsequent cleavage of S-N bond.

Photocatalytic degradation of Sulfamonomethoxine by mesoporous phosphorus-doped titania under simulated solar light irradiation

Chemosphere 2021 Dec;285:131553.PMID:34271470DOI:10.1016/j.chemosphere.2021.131553.

Photocatalytic degradation of Sulfamonomethoxine (SMM) by mesoporous phosphorus-doped TiO2 (P-TiO2) was studied under simulated solar light irradiation. The morphological structure and chemical composition of P-TiO2 were analyzed by XRD, SEM, HRTEM, BET, XPS and FTIR. Using the central composite design (CCD) of response surface methodology (RSM), the degradation of SMM was investigated with a range of antibiotic concentrations (4-8 mg L-1), catalyst dosages (400-900 mg L-1), P doping amounts (5-15 wt %) and irradiation time (90-150 min). The Ti-O-P bond formed during the calcination of TiO2, thereby generating plate-like P-TiO2, where P was uniformly distributed. Phosphorus doping can stabilize anatase TiO2, which has a larger specific surface area and a lower average particle and pore size than bare TiO2. The result obtained from the RSM model showed a significant correlation between the predicted values and the experimental results of SMM degradation (P < 0.05). Under the optimal experimental conditions (antibiotic concentration = 6 mg/L, catalyst dosage = 800 mg/L, P doping = 5 wt% and irradiation time = 90 min), the degradation rate of SMM was 99.51%, and the TOC was 50%. Toxicity showed a considerable reduction towards Vibrio-qinghaiensis sp.-Q67 after SMM photocatalytic degradation. Through free radical capture experiments, LC-MS detection and DFT calculations, the possible photocatalytic degradation mechanism of SMM using P-TiO2 as the catalyst was revealed.

Biotransformation of Sulfamonomethoxine in a granular sludge system: Pathways and mechanisms

Chemosphere 2023 Feb;313:137508.PMID:36493889DOI:10.1016/j.chemosphere.2022.137508.

The biotransformation of Sulfamonomethoxine (SMM) was studied in an aerobic granular sludge (AGS) system to understand the role of sorption by microbial cells and extracellular polymeric substances (EPS) and the role of functional microbe/enzyme biodegradation. Biodegradation played a more important role than adsorption, while microbial cells covered with tightly bound EPS (TB-EPS) showed higher adsorption capacity than microbial cells themselves or microbial cells covered with both loosely bound EPS (LB-EPS) and TB-EPS. The binding tests between EPS and SMM and the spectroscopic analyses (3D-EEM, UV-Vis, and FTIR) were performed to obtain more information about the adsorption process. The data showed that SMM could interact with EPS by combining with aromatic protein compounds, fulvic acid-like substances, protein amide II, and nucleic acids. Batch tests with various substances showed that SMM removal rates were in an order of NH2OH (60.43 卤 2.21 渭g/g SS) > NH4Cl (52.96 卤 0.30 渭g/g SS) > NaNO3 (31.88 卤 1.20 渭g/g SS) > NaNO2 (21.80 卤 0.42 渭g/g SS). Hydroxylamine and hydroxylamine oxidoreductase (HAO) favored SMM biotransformation and the hydroxylamine-mediated biotransformation of SMM was more effective than others. In addition, both ammonia monooxygenase (AMO) and CYP450 were able to co-metabolize SMM. Analysis of UPLC-QTOF-MS indicated the biotransformation mechanisms, revealing that acetylation of arylamine, glucuronidation of sulfonamide, deamination, SO2 extrusion, and 未 cleavage were the five major transformation pathways. The detection of TP202 in the hydroxylamine-fed Group C indicated a new biotransformation pathway through HAO. This study contributes to a better understanding of the biotransformation of SMM.